Brain drug delivery systems, allied with their characteristics for overcoming the blood-brain barrier (BBB). Implantable delivery ensures that drug preparations are directly implanted into the brain by surgery or through special instruments. In cell penetrating peptide mediated BBB crossing, positively charged particles are modified onto the surface of the preparations to heighten the interactions. Temporary disruption of BBB can currently be achieved through ultrasound or magnetic disruption technologies. Intranasal delivery enables drug preparations to cross the olfactory mucosa in the nasal cavity, to be transported into the brain. Finally, molecules, ligands or substrates can be modified onto the surface of the preparations via receptors, carriers or transporter-mediated approaches.
Related content
Social and physical exposome factors—like poverty, pollution, and inequality—accumulate over time, shaping biological aging and cognitive decline. Through inflammation and cellular stress, these exposures drive neurodegeneration, highlighting the need for longitudinal, integrative research.
The exposome reframes dementia as the product of cumulative physical and social exposures-like pollution, nutrition, and inequality-across life. These factors shape brain aging through inflammation and epigenetic change. Lifespan, global studies are key to equitable dementia prevention.
